David H. Ledbetter, Ph.D., FACMG
Professor, Department of Clinical Sciences
Associate Director, Insitute for Pediatric Rare Diseases
Florida State University College of Medicine

After serving as Executive Vice President and Founding Chief Scientific Officer at Geisinger for more than ten years (2010-2021), Dr. Ledbetter returned to Florida first at UF-Jacksonville and more recently at FSU College of Medicine, where he continues his NIH-funded research on the genetic basis of autism and related neurodevelopmental disorders. Previously he held academic and leadership positions at Baylor College of Medicine, Emory University School of Medicine, where he was the Robert W. Woodruff Professor of Human Genetics, and the University of Chicago where he was the Marjorie I. and Bernard A. Mitchell Professor and Founding Chair of the Department of Human Genetics (1996-2003). He is a graduate of Tulane University and earned his Ph.D. at the University of Texas-Austin.  He is an internationally recognized expert in Genomics and Precision Medicine, having discovered the genetic causes of Prader-Willi syndrome and Miller-Dieker syndrome and focusing his ongoing research efforts on discovering the genetic causes of childhood neurodevelopmental disorders including autism. He has been a pioneer in the translation of new genomics technologies into clinically useful genetic tests for early diagnosis and intervention, including telomere FISH, chromosomal microarray (CMA), and most recently, exome and genome sequencing. His current research interest includes determining the clinical utility of genome sequencing in healthy newborns to determine if it is feasible as part of routine newborn screening.

Disclosures:

Financial: Salary – Florida State University College of Medicine, Scientific Consultant to Nest Genomics, Inc. and MyOme, Inc. and Honorarium for FSU Summer Institute

Non-Financial: None